CRISPRed crops and agbiotech’s future
In this issue:
- Bioeconomy: Uncertainty about review of EU strategy hampers investments
- Orphan Drugs: How can healthcare systems establish value-based pricing?
- Allergies New biotech solutions target oversensitive immune systems
- Biofairs Compass: Your guide to relevant EU life sciences events in H2/2017
- Focus Biomanufacturing: Bright future for biomanufacturers
- Interviews with Federico Pollano, Business Development & Contract Manufacturing Director, Polpharma and Daniel Oliver, CEO, Capital Cell, Barcelona
- News from our partner associations European Biotechnology Network, EAPB, EDMA, DIA, BIO Deutschland and the Swiss Biotech Association